138 related articles for article (PubMed ID: 3051071)
21. Resistant geriatric depressions and therapeutic response to monoamine oxidase inhibitors.
Georgotas A; Friedman E; McCarthy M; Mann J; Krakowski M; Siegel R; Ferris S
Biol Psychiatry; 1983 Feb; 18(2):195-205. PubMed ID: 6830930
[TBL] [Abstract][Full Text] [Related]
22. Phenelzine and imipramine in mood reactive depressives. Further delineation of the syndrome of atypical depression.
Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Wager SG; Nunes E; Rabkin JG; Tricamo E; Markowitz J; Klein DF
Arch Gen Psychiatry; 1989 Sep; 46(9):787-93. PubMed ID: 2673130
[TBL] [Abstract][Full Text] [Related]
23. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
24. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
Davidson J; McLeod MN; White HL
Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
[TBL] [Abstract][Full Text] [Related]
26. Duration of antidepressant trials: clinical and research implications.
Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
[TBL] [Abstract][Full Text] [Related]
27. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
28. Atypical depression, panic attacks, and response to imipramine and phenelzine. A replication.
Quitkin FM; McGrath PJ; Stewart JW; Harrison W; Tricamo E; Wager SG; Ocepek-Welikson K; Nunes E; Rabkin JG; Klein DF
Arch Gen Psychiatry; 1990 Oct; 47(10):935-41. PubMed ID: 2222132
[TBL] [Abstract][Full Text] [Related]
29. The influence of panic attacks on response to phenelzine and amitriptyline in depressed outpatients.
Kayser A; Robinson DS; Yingling K; Howard DB; Corcella J; Laux D
J Clin Psychopharmacol; 1988 Aug; 8(4):246-53. PubMed ID: 3062042
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission.
Stewart JW; Tricamo E; McGrath PJ; Quitkin FM
Am J Psychiatry; 1997 Jan; 154(1):31-6. PubMed ID: 8988955
[TBL] [Abstract][Full Text] [Related]
31. Phenelzine vs placebo in 50 patients with bulimia.
Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
[TBL] [Abstract][Full Text] [Related]
32. Study duration in antidepressant research: advantages of a 12-week trial.
Quitkin FM; Rabkin JG; Stewart JW; McGrath PJ; Harrison W
J Psychiatr Res; 1986; 20(3):211-6. PubMed ID: 3534246
[TBL] [Abstract][Full Text] [Related]
33. Psychopharmacologic validation of atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of phenelzine in geriatric depression.
Lazarus LW; Groves L; Gierl B; Pandey G; Javaid JI; Lesser J; Ha YS; Davis J
Biol Psychiatry; 1986 Jun; 21(7):699-701. PubMed ID: 3708040
[No Abstract] [Full Text] [Related]
35. Antidepressant drug therapy in psychotic depression.
Davidson JR; McLeod MN; Kurland AA; White HL
Br J Psychiatry; 1977 Nov; 131():493-6. PubMed ID: 338082
[TBL] [Abstract][Full Text] [Related]
36. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
[TBL] [Abstract][Full Text] [Related]
37. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
Georgotas A; McCue RE; Friedman E; Cooper TB
J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
[TBL] [Abstract][Full Text] [Related]
38. Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication.
Stewart JW; Halbreich U
Biol Psychiatry; 1989 Jan; 25(1):33-8. PubMed ID: 2643443
[TBL] [Abstract][Full Text] [Related]
39. A double-blind trial of phenelzine in bulimia.
Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
J Psychiatr Res; 1985; 19(2-3):485-9. PubMed ID: 3900362
[TBL] [Abstract][Full Text] [Related]
40. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]